Posts

Showing posts from January, 2021

Demand for Vacuum Insulated Panels (VIPs) Dropped Sharply in 2020 and Expected to Rebound Significantly in 2021 - Market Report by Industry Experts, Inc.

Image
Industry Experts, Inc. released an updated 2021 version of the market research report " Vacuum Insulation Panels (VIPs) – A Global Market Overview ". As per the new report, VIPs demand in cold chain logistics is projected to post the robust growth in 2021, particularly due to COVID-19 Pandemic, as the pharmaceutical products need the sophisticated thermal packaging. The market development of VIPs has been largely impacted by the evolution in regulations set for energy efficiency in buildings, refrigerators, hot water storage systems and automobiles. Refrigeration manufacturers are increasingly employing VIPs for achieving optimum energy efficiency. Cold chain logistics for pharmaceutical products is also under intense regulatory scrutiny, which has increased the need for reliable and high performance thermal packaging, which has boosted the market for VIPs. The impact of COVID-19 pandemic on vacuum insulation panels (VIPs) demand is expected to differ in intensity dependin

Global Biosimilars Market Projected to Witness a Robust Growth and Reach $71.8 Billion by 2026 - Market Report (2020-2026) by Industry Experts, Inc

Image
Industry Experts, Inc. published the new 2021 version of its global market report on Biosimilars. The new version of the report entitled " Global Biosimilars Market – Products, Applications and Regulations " reveals that the global market for Biosimilars application in Oncology therapeutics is the largest in 2020 closely followed by Autoimmune Disorders. Due to the COVID-19 Pandemic, telehealth and tele-detailing (also called remoter detailing or web calls) have set forth that allow a biosimilars companies' commercialization branch to have a wide range with less few reps. Also, the fluidity of the labor market is another new dynamic allowing for a greater diversity of commercialization build-out models. These new dynamics greatly change how companies should be building models of commercialization that also has vast implications for potential BD partnerships. The solution to 'build versus buy' is no longer driven by the size, scale, and cost of a sales force leadi